1-2 of 2
Sergio Cogliatti, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Annette M. Staiger, PhD, Marita Ziepert, Heike Horn, PhD, David W. Scott, Thomas F. E. Barth, MD, Heinz-Wolfram Bernd, MD, Alfred C. Feller, MD, Wolfram Klapper, MD, Michael Hummel, Harald Stein, MD PhD, Dido Lenze, Martin-Leo Hansmann, MD, Sylvia Hartmann, MD, Peter Moeller, MD, Sergio Cogliatti, MD, Georg Lenz, MD, Lorenz H. Truemper, MD PhD, Markus Loeffler, MD PhD, Norbert Schmitz, MD, PhD, Michael Pfreundschuh, MD, Andreas Rosenwald, MD, German Ott
Journal: Blood
Blood (2016) 128 (22): 151.
https://doi.org/10.1182/blood.V128.22.151.151
Published: 2016
Journal Articles

A Multicentre Phase II Trial Testing Gemcitabine in the Treatment of Patients with Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma: SAKK 36/03.

Felicitas Hitz, MD, Giovanni Martinelli, MD, Emanuele Zucca, MD, Walter Mingrone, MD, Roger Von Moos, MD, Mathew Simcock, Jenny Peterson, Sergio Cogliatti, MD, Francesco Bertoni, MD, Michele Ghielmini, MD
Journal: Blood
Blood (2007) 110 (11): 4454.
https://doi.org/10.1182/blood.V110.11.4454.4454
Published: 2007